DR. Grieten SRL
DR. Grieten reported total assets of €1.95m at the end of the 2025 financial year (annual accounts filed with the NBB on 11 May 2026).
The score of DR. Grieten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. Grieten's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 May 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 04 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
DR. Grieten's financial analysis
- Solvency91.6%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. Grieten
DR. Grieten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0455.898.515
- VAT number
- BE0455898515
- Peppol
- Registered · 0208:0455898515 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Aug 1995
- Registered office
- 3600 Genk
- Latest accounts
- 2025 · filed on 11 May 2026
- Activity
- Medical specialists activities (NACE 86220)
DR. Grieten (SRL) has been based in Genk since 1995, active in: medical specialists activities. For 2025, it reports a net profit of 177,627 € and equity of €1.79m; its revenue is not published. Its solvency stands at 91.6%, above the median of its sector (72.2%).
Companies similar to DR. Grieten
Companies in the same business, of comparable size and area, outside its group.
- Giljom Activities of holding companies Leuven · balance sheet €1.95m
- Celeste Holding Activities of holding companies Schilde · balance sheet €1.95m
- eureKASYNBIO Manufacture of basic pharmaceutical products Brussels · balance sheet €1.96m
- Open View Invest Financial service activities, except insurance and pension funding Léglise · balance sheet €1.96m
- Joma Holding Activities of head offices Knokke-Heist · balance sheet €1.95m
- Royalton Holding Activities of holding companies Antwerp · balance sheet €1.96m
- Deromco Activities of holding companies Destelbergen · balance sheet €1.95m
- Immo – EN Beheersmaatschappij V.C.V. Activities of holding companies Antwerp · balance sheet €1.96m
Frequently asked questions about DR. Grieten
What is the revenue of DR. Grieten?
DR. Grieten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. Grieten?
In Belgium, the VAT number is the company number prefixed with BE: BE0455898515 for DR. Grieten, if the company is VAT-registered. Its company number (CBE) is 0455.898.515.
Where is the registered office of DR. Grieten?
According to the CBE register, the registered office of DR. Grieten is in 3600 Genk.
What is the equity of DR. Grieten?
At the close of the 2025 financial year, the equity of DR. Grieten amounts to 1,789,140 €, a solvency of 91.6% of total assets.
Who manages DR. Grieten?
The register lists 1 active mandates at DR. Grieten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR. Grieten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →